Bristol Myers Squibb BMY
NYSE BMY
$61.53 -1.47 (-2.33%)
As of: Oct 23, 2026 · 3:59 PM EDT

Bristol Myers Squibb (BMY) Return on Sales [ROS] (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) reported Return on Sales [ROS] of 2.77% for Q2 2026, up 15.81 percentage points from -13.03% a year earlier and up 4.36 percentage points from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Bristol Myers Squibb's Return on Sales [ROS] came in at -5.63%, up 10.26 percentage points year-over-year; for FY2025, it was -9.56%, up 36.71 percentage points from FY2024.

  • Return on Sales [ROS] has a five-year change of +34.29 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at -46.27% in FY2024 (-41.26 pp), -5.01% in FY2023 (+0.25 pp), -5.25% in FY2022 (-1.28 pp) and -3.97% in FY2021 (+39.88 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Sales [ROS] since Q3 2018.
  • Year over year, Return on Sales [ROS] gained in five of the last eight quarters, with an average year-over-year change of +16.03 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q1 2025 (a gain of 121.22 percentage points); the low point was Q1 2024 (a drop of 123.57 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -1.58% (Q1 2026), -21.01% (Q4 2025) and -2.63% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 24.35%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 37.86%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -3.52%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 20.57%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 28.37%
10 Bristol Myers Squibb 125.99 Bn 77.26 Bn 9.25 Bn 2.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.77%
Mar 31, 2026 -1.58%
Dec 31, 2025 -21.01%
Sep 30, 2025 -2.63%
Jun 30, 2025 -13.03%
Mar 31, 2025 -0.55%
Dec 31, 2024 -37.57%
Sep 30, 2024 -10.77%
Jun 30, 2024 -16.24%
Mar 31, 2024 -121.77%
Dec 31, 2023 -9.33%
Sep 30, 2023 -3.36%
Jun 30, 2023 -9.06%
Mar 31, 2023 1.80%
Dec 31, 2022 -6.44%
Sep 30, 2022 -1.28%
Jun 30, 2022 -6.41%
Mar 31, 2022 -6.73%
Dec 31, 2021 -4.16%
Sep 30, 2021 -1.15%
API Access

Bristol Myers Squibb Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BMY&period=max&api_key=YOUR_API_KEY